Detailed Program
- Current Page
- Program > Detailed Program
English Session
Korean SessionMorning Session 2 
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room B | ||||
| 08:00-09:00 |
KOR
Morning Session 2
|
Seok Min Kang (Yonsei Univ., Korea) | ||
| 08:00-08:30 | Jardiance, The First Successful Result for Chronic Heart Failure with Preserved Ejection Fraction | Mi-Na Kim (Korea Univ., Korea) | ||
| 08:30-09:00 | Should Jardiance be Used as 1st Essential Medication for Chronic Heart Failure, Regardless of LVEF | Kyeong-Hyeon Chun (Yonsei Univ., Korea) | ||
Hypertrophic Cardiomyopathy in 2025
|
Room B Learning Objective + Session Rationale + |
||||
| 09:00-10:20 | ENG Hypertrophic Cardiomyopathy in 2025 |
Dong Heon Yang (Kyungpook National Univ., Korea)
, Eui-Young Choi (Yonsei Univ., Korea) |
||
| This session aims to provide an up-to-date understanding of the evolving landscape of hypertrophic cardiomyopathy (HCM) management by addressing advances in genetics and precision medicine, the role of cardiac imaging in the era of myosin inhibitors, and the development of novel pharmacologic therapies. | ||||
| As knowledge and technology in HCM rapidly advance, 2025 represents a turning point in the way this disease is diagnosed, risk-stratified, and treated. | ||||
| 09:00-09:20 | Genetics and Precision Medicine in Diagnosing and Risk Stratification in HCM |
|
Seitaro Nomura (The Univ. of Tokyo, Japan) | |
| 09:20-09:40 | Role of Imaging in HCM in the Era of Cardiac Myosin Inhibitor |
|
Chi Young Shim (Yonsei Univ., Korea) | |
| 09:40-10:00 | From Beta-blockers to Myosin Inhibitors: Evolving Pharmacologic Therapies for HCM |
|
Carolyn Ho (Brigham and Women's Hospital, USA) | |
| 10:00-10:20 | Discussion |
Jang-Won Son (Yeungnam Univ., Korea) , Hyun-Jung Lee (Yonsei Univ., Korea) , Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea) , Jung Hyun Choi (Pusan National Univ., Korea) |
||
[Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management
|
Room B Learning Objective + Session Rationale + |
||||
| 10:40-12:00 | ENG [Joint Session with HFA-ESC] How to Enhance a Personalized Strategy for HF Management |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Gianluigi Savarese (Karolinska Institutet, Sweden) |
||
| This session aims to explore practical and evidence-based strategies for implementing personalized heart failure (HF) care, focusing on decongestion, biomarker-guided therapy, and optimization during the transitional period following acute decompensation. | ||||
| As heart failure management evolves toward individualized care, a personalized approach is essential to improve patient outcomes across diverse clinical scenarios. This joint session with the European Society of Cardiology – Heart Failure Association (HFA-ESC) highlights critical components of tailored HF management. | ||||
| 10:40-11:00 | Dietary Sodium, Fluid Intake and Decongestion in Heart Failure |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 11:00-11:20 | Biomarkers: Optimizing Treatment Guidance in Heart Failure |
|
Byung Su Yoo (Yonsei Wonju Univ., Korea) | |
| 11:20-11:40 | Optimization of HF Care during Transitional Period in Acute HF Patients |
|
Marco Metra (University of Brescia, Italy) | |
| 11:40-12:00 | Discussion |
Sung-Hee Shin (Inha Univ., Korea) , Chi Young Shim (Yonsei Univ., Korea) , In-Chang Hwang (Seoul National Univ., Korea) , Novi Yanti Sari (Siloam Hospitals Lippo Village, Jakarta, Indonesia) |
||
Luncheon Session 5 
Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT
| Room B | ||||
| 12:00-13:00 |
ENG
Luncheon Session 5 Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT |
Kyu Hyung Ryu (Techo Santepheap National Hospital, Cambodia)
, Seongwoo Han (Hallym Univ., Korea) |
||
| 12:00-12:45 | Empagliflozin in Chronic Heart Failure: Foundational Therapy & Practical GDMT | Barry Greenberg (Univ. of California San Diego, USA) | ||
| 12:45-13:00 | Discussion | |||
Hematologic Problems Related to Heart Failure
|
Room B Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | ENG Hematologic Problems Related to Heart Failure |
Eunseok Jeon (Sungkyunkwan Univ., Korea)
, Chang-Ki Min (The Catholic Univ., Korea) |
||
| To understand the pathophysiology and clinical implications of anemia, CHIP, cardiac amyloidosis, and hematologic malignancies in heart failure, and how these conditions impact diagnostic and therapeutic strategies. | ||||
| This session will explore key hematologic conditions frequently encountered in heart failure, including anemia, clonal hematopoiesis, and amyloidosis. It will also highlight the cardiovascular complications of hematologic malignancies and treatment-related cardiotoxicity. Through case-based and mechanistic insights, the session aims to provide a multidisciplinary perspective on integrating hematologic factors into heart failure management. | ||||
| 13:00-13:15 | Iron Deficiency, Anemia, and Transfusion in Heart Failure |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 13:15-13:30 | CHIP (Clonal Hematopoiesis of Indeterminate Potential) in CVD: A New Frontier in Cardio-Hematology |
|
Jun-Bean Park (Seoul National Univ., Korea) | |
| 13:30-13:45 | AL Amyloidosis: What Cardiologists Need to Know |
|
Jeong-Eun Yi (The Catholic Univ., Korea) | |
| 13:45-14:00 | Atrial Fibrillation in Cardiac Amyloidosis |
|
Yasuhiro Izumiya (Kumamoto Univ., Japan) | |
| 14:00-14:20 | Discussion |
Kyu-Yong Ko (Inje Univ., Korea) , Hyung Yoon Kim (Incheon Sejong Hospital, Korea) , Kyeong-Hyeon Chun (Yonsei Univ., Korea) |
||
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion
| Room B | ||||
| 14:20-15:30 |
ENG
When to Look for Amyloidosis? Early Clinical Clues to Raise Diagnostic Suspicion |
Jin-Oh Choi (Sungkyunkwan Univ., Korea)
, Marcus Urey (Univ. of California San Diego, USA) |
||
| 14:20-14:50 | Navigating Early Diagnosis of ATTR Amyloidosis in Clinical Practice |
|
Marcus Urey (Univ. of California San Diego, USA) | |
| 14:50-15:05 | Sharing Real World Experiences of Diagnosed Amyloidosis I |
|
Sung-Hee Shin (Inha Univ., Korea) | |
| 15:05-15:20 | Sharing Real World Experiences of Diagnosed Amyloidosis II |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:20-15:30 | Discussion | Yoonjee Park (Bucheon Sejong Hospital, Korea) | ||
[Joint Session with KHRS] Arrhythmia and Device Therapy in HF
|
Room B Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | ENG [Joint Session with KHRS] Arrhythmia and Device Therapy in HF |
Dae-Gyun Park (Hallym Univ., Korea)
, Seil Oh (Seoul National Univ., Korea) |
||
| To understand the indications, benefits, and risks of catheter ablation and cardiac resynchronization therapy in heart failure patients with arrhythmia. | ||||
| This session will review catheter ablation strategies in heart failure with atrial fibrillation, including patient selection and real-world outcomes. It will also discuss the detection and management of asymptomatic arrhythmias, and present practical guidance on optimizing CRT. By integrating electrophysiologic interventions into heart failure care, the session aims to improve rhythm control and patient prognosis. | ||||
| 15:40-15:55 | HF with Atrial Fibrillation: Patients for Whom Catheter Ablation May be Beneficial |
|
Jun Kim (Ulsan Univ., Korea) | |
| 15:55-16:10 | HF with Atrial Fibrillation: Common and Rare Concerns of Catheter Ablation |
|
Jiwon Seo (Yonsei Univ., Korea) | |
| 16:10-16:25 | How to Diagnose and Manage Asymptomatic Arrhythmia in HF Patients? |
|
Eue-Keun Choi (Seoul National Univ., Korea) | |
| 16:25-16:40 | A Practical Approach to Optimize Cardiac Resynchronization Therapy |
|
Wilfried Mullens (Hospital Oost-Limburg, Belgium) | |
| 16:40-17:00 | Discussion |
Tae-Hoon Kim (Yonsei Univ., Korea) , Yoonjee Park (Bucheon Sejong Hospital, Korea) , Youngjin Cho (Seoul National Univ., Korea) |
||
KSHF Lifetime Achievement Award
| Room B | ||||
| 17:10-18:10 | KOR KSHF Lifetime Achievement Award |
Dae-Gyun Park (Hallym Univ., Korea)
, Byung Su Yoo (Yonsei Wonju Univ., Korea) |
||
| 17:10-17:15 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:15-17:35 | History of Heart Failure Treatment |
|
Myung-A Kim (Seoul National Univ., Korea) | |
| 17:35-17:40 | Introduction of Lifetime Achievement Award | Wook-Jin Chung (Gachon Univ., Korea) | ||
| 17:40-18:00 | The Heart Failure Odyssey: From Bench to Cyber |
|
Dong-Ju Choi (Seoul National Univ., Korea) | |
| 18:00-18:10 | Congratulatory Remarks | Byung Su Yoo (Yonsei Wonju Univ., Korea) | ||
- The Korean Society of Heart Failure
- TEL: +82-2-3275-5335 | FAX: +82-2-3275-5336 | E-Mail: kshf3@kshf.or.kr
- Business Registration No. : 234-82- 63394 | Name of Representative : ByungSu Yoo
